Evaluation of the clinical utility of the FebriDx® test for viral and bacterial upper respiratory infection in a UK A&E department
- Conditions
- Acute upper respiratory infectionsRespiratory
- Registration Number
- ISRCTN14380378
- Lead Sponsor
- niversity of Leeds
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 908
1. Participant reports a temperature of >=37.5 degrees C in the last 3 days or exhibited at visit
2. Participant reports symptoms within the last 7 days that are indicative of a new, acute respiratory infection in the opinion of the research team. (Symptoms can include but are not limited to: runny nose, nasal congestion, sore throat, new cough, hoarse voice and shortness of breath).
3. Participant is aged >= 16 years
4. Capacity to consent
5. Ability to understand English
1. The participant is immunocompromised or taking chemotherapy, oral steroids, or interferon
2. The participant is currently prescribed antibiotics, antivirals or had a recent live vaccine
3. The participant has a pyrexia which has lasted more than 3 days prior to the visit to accident and emergency department
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method